AstraZeneca applies for approval of Covid-19 in European Union

The European Medicines Agency (EMA) has announced that AstraZeneca has applied for approval of their Covid-19 which has been developed by AstraZeneca and Oxford University.

According to the EMA "the assessment of the vaccine, known as COVID-19 Vaccine AstraZeneca, will proceed under an accelerated timeline" and added that "an opinion on the marketing authorisation could be issued by 29 January during the meeting of EMA’s scientific committee for human medicines (CHMP), provided that the data submitted on the quality, safety and efficacy of the vaccine are sufficiently robust and complete and that any additional information required to complete the assessment is promptly submitted."